# Boomerang Medical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/boomerang-medical

- Industry: Healthcare
- Headquarters: Mountain View, US
- Website: www.boomerangmedical.com
- Total disclosed funding: $38M
- Latest round: Series B (Sep 4, 2025)
- Investors on record: 2

## About

Founded in 2021 and based in California, US, Boomerang Medical, Inc. operates as a healthcare platform that develops an electric device to aid in the treatment of patients suffering from autoimmune diseases. In September 2025, Boomerang Medical, Inc. raised USD 20 million in series B funding co-led by returning investors Hatteras Venture Partners and Arboretum Ventures. As part of the transaction, Tom Shebab of Arboretum Ventures will join the company's board.

The company provides a device-focused approach to treating autoimmune diseases by using bioelectronic medicine to harness the body's own physiology. The company creates bioelectronic medicine, which focuses on electric signaling within a patient's nervous system to help the body restore homeostasis with the goal of eliminating chronic inflammatory pathways.

The company plans to use the September 2025 funding to accelerate its clinical trials and development of its neuromodulation therapy for autoimmune diseases.

## Funding rounds

- Series B, Sep 4, 2025, $20M — Hatteras Venture Partners, Arboretum Ventures
- Series A, Nov 1, 2022, $15M — Hatteras Venture Partners, Arboretum Ventures
- Seed, Oct 18, 2021, $3M — Arboretum Ventures

## Investors

- Arboretum Ventures (https://capitalatlas.ai/funds/arboretum-ventures) — Seed, Series A, Series B
- Hatteras Venture Partners (https://capitalatlas.ai/funds/hatteras-venture-partners) — Series A, Series B